S. Arebee, A. (2025) “CRISPR Gene-Editing Therapies for Sickle Cell Disease and Beta- Thalassemia: Clinical Outcomes, Risks and Safety Profiles. A Systematic Review”, Libyan Journal of Medical and Applied Sciences, 3(4), pp. 102–108. doi: 10.64943/ljmas.v3i4.254.